CE

Cell Bio Human Tech Co., Ltd

318160 | KO

Overview

Corporate Details

ISIN(s):
KR7318160009
LEI:
Country:
South Korea
Address:
경기도 안양시 동안구 시민대로 401 대륭테크노타운15차 제2001호,제2101호, 안양시
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

No description available.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-19 00:00
Transaction in Own Shares
주요사항보고서(자기주식처분결정)
Korean 31.8 KB
2025-09-19 00:00
Capital/Financing Update
주요사항보고서(교환사채권발행결정)
Korean 53.0 KB
2025-08-28 00:00
Transaction in Own Shares
주요사항보고서(자기주식취득신탁계약해지결정)
Korean 28.2 KB
2025-08-28 00:00
Transaction in Own Shares
주요사항보고서(자기주식취득신탁계약해지결정)
Korean 28.2 KB
2025-08-28 00:00
Transaction in Own Shares
신탁계약해지결과보고서
Korean 20.6 KB
2025-08-28 00:00
Transaction in Own Shares
신탁계약해지결과보고서
Korean 22.3 KB
2025-08-28 00:00
Transaction in Own Shares
[기재정정]주요사항보고서(자기주식취득신탁계약해지결정)
Korean 31.1 KB
2025-08-28 00:00
Interim / Quarterly Report
[기재정정]반기보고서 (2025.06)
Korean 1.2 MB
2025-08-18 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.3 KB
2025-08-14 00:00
Interim / Quarterly Report
반기보고서 (2025.06)
Korean 1.2 MB
2025-06-02 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 7.0 KB
2025-05-27 00:00
Major Shareholding Notification
신탁계약에의한취득상황보고서
Korean 52.6 KB
2025-05-27 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.3 KB
2025-05-14 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 1.1 MB
2025-04-02 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.4 KB

Automate Your Workflow. Get a real-time feed of all Cell Bio Human Tech Co., Ltd filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Cell Bio Human Tech Co., Ltd

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Cell Bio Human Tech Co., Ltd via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Transgene Logo
Developing viral immunotherapies like vaccines and oncolytic viruses to treat solid tumors.
France
TNG
TRANS GENIC GROUP INC. Logo
Offers drug discovery CRO services (gene editing, trials) and business investment/consulting.
Japan
2342
TriSalus Life Sciences, Inc. Logo
Oncology tech firm enhancing drug delivery and immunotherapy for solid liver & pancreas tumors.
United States of America
TLSI
TScan Therapeutics, Inc. Logo
Developing TCR-engineered T-cell therapies for solid and hematologic cancers.
United States of America
TCRX
Tsubota Laboratory Incorporated Logo
Developing pharmaceuticals and medical devices for ophthalmic and brain diseases.
Japan
4890
TuHURA Biosciences, Inc./NV Logo
Phase 3 immuno-oncology firm developing therapeutics to overcome cancer therapy resistance.
United States of America
HURA
Tyra Biosciences, Inc. Logo
Biotech developing precision FGFR medicines for cancer and genetic disorders.
United States of America
TYRA
UCAR Logo
A nonprofit consortium managing atmospheric research and providing resources to the scientific community.
France
ALUCR
Ulisse Biomed Logo
Provides a portable platform for rapid point-of-need genetic analysis and diagnostics.
Italy
UBM
UNIVERSAL DISPLAY CORP \PA\ Logo
Develops and licenses OLED technologies and materials for the display and lighting industries.
United States of America
OLED

Talk to a Data Expert

Have a question? We'll get back to you promptly.